Thromb Haemost 2003; 90(04): 598-606
DOI: 10.1160/TH03-04-0220
Review Article
Schattauer GmbH

Migration of leukocytes through the vessel wall and beyond

Rashmi Yadav
1   Cardiovascular Medicine Unit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
,
Karen Y. Larbi
1   Cardiovascular Medicine Unit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
,
Rebecca E. Young
1   Cardiovascular Medicine Unit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
,
Sussan Nourshargh
1   Cardiovascular Medicine Unit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
› Author Affiliations
Financial support: This work was funded by The Wellcome Trust and the British Heart Foundation.
Further Information

Publication History

Received 09 April 2003

Accepted after revision 16 June 2003

Publication Date:
05 December 2017 (online)

Summary

The migration of leukocytes from the vascular lumen to sites of infection and/or injury in the extravascular tissue involves a series of sequential and coordinated molecular and cellular events with the resultant primary response being that of reduced leukocyte velocity within the blood stream, followed by leukocyte firm adhesion to endothelial cells lining the vessel wall and eventually migration through the vessel wall. Despite the growing knowledge of the mechanisms that mediate initial interaction of leukocytes with the endothelium, very little is known about the mechanisms that mediate and regulate leukocyte migration through the venular wall, the endothelium and its associated perivascular basement membrane. This review, whilst giving a brief outline of the stepwise cascade of molecular interactions involved in this process and the methods employed to investigate leukocyte migration in vivo, focuses primarily on mechanisms of leukocyte transmigration, the final step in the process of leukocyte emigration. Furthermore, special emphasis is placed on discussing the process and the mechanisms involved in leukocyte migration through the basement membrane, a structure that presents significant impedance to transmigrating leukocytes but is seldom investigated in the context of leukocyte transmigration in vivo. The review also discusses the growing evidence supporting the concept that leukocyte transmigration is not only a response that describes the passage of leukocytes through the venular wall, but also acts as a means of regulating leukocyte responsiveness beyond the vessel wall, i.e. within the extravascular tissue.

This publication was partially financed by Serono Foundation for the Advancement of Medical Science.

Part of this paper was originally presented at the 2nd International Workshop on New Therapeutic Targets in Vascular Biology from February 6-9, 2003 in Geneva, Switzerland.

 
  • References

  • 1 Butcher EC. et al. Lymphocyte homing and homeostasis. Science 1996; 272: 60-6.
  • 2 Imhof BA. et al. Leukocyte migration and adhesion. Adv Immunol 1995; 58: 345-416.
  • 3 Sriramarao P. et al. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J Immunol 1994; 153: 4238-46.
  • 4 Alon R. et al. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995; 128: 1243-53.
  • 5 Berlin C. et al. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995; 80: 413-22.
  • 6 Weber C. et al. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci U S A 1996; 93: 10939-44.
  • 7 Constantin G. et al. Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000; 13: 759-69.
  • 8 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
  • 9 Johnson-Leger C. et al. The parting of the endothelium: miracle, or simply a junctional affair?. J Cell Sci 2000; 113 Pt (06) 921-33.
  • 10 Worthylake RA. et al. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol 2001; 13: 569-77.
  • 11 Erickson AC. et al. Still more complexity in mammalian basement membranes. J Histo-chem Cytochem 2000; 48: 1291-306.
  • 12 Dejana E. et al. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001; 86: 308-15.
  • 13 Hirschi KK. et al. Pericytes in the microvasculature. Cardiovasc Res 1996; 32: 687-98.
  • 14 Aumailley M. et al. The role of laminins in basement membrane function. J Anat 1998; 193 Pt (01) 1-21.
  • 15 Frieser M. et al. Cloning of the mouse laminin α4 cDNA. Expression in a subset of endothelium. Eur J Biochem 1997; 246: 727-35.
  • 16 Sixt M. et al. Endothelial cell laminin iso-forms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 2001; 153: 933-46.
  • 17 Sorokin L. et al. Expression of novel 400-kDa laminin chains by mouse and bovine endothelial cells. Eur J Biochem 1994; 223: 603-10.
  • 18 Dangerfield J. et al. PECAM-1 (CD31) homo-philic interaction up-regulates α6β1 on transmigrated neutrophils in vivo and plays a functional role in the ability of α6 integrins to mediate leukocyte migration through the peri-vascular basement membrane. J Exp Med 2002; 196: 1201-12.
  • 19 Burns AR. et al. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J Immunol 1997; 159: 2893-903.
  • 20 Verbeek MM. et al. T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J Immunol 1995; 154: 5876-84.
  • 21 Stein B. et al. Transmigration of leukocytes. In Endothelium in clinical practice: source and target of novel therapies. Rubanyi GM, and Dzau VJ. New York: Marcel Dekker, Inc; 1997: 149-202.
  • 22 Larbi KY. et al. VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration. Blood 2000; 96: 3601-9.
  • 23 Larbi KY. et al. P-selectin mediates IL-13-induced eosinophil transmigration but not eotaxin generation in vivo: a comparative study with IL-4-elicited responses. J Leukoc Biol 2003; 73: 65-73.
  • 24 Menger MD. et al. Scope and perspectives of intravital microscopy-bridge over from in vitro to in vivo. Immunol Today 1993; 14: 519-22.
  • 25 Kubes P. et al. Leukocyte recruitment in the microcirculation: the rolling paradigm revisited. News Physiol Sci 2001; 16: 76-80.
  • 26 Huang AJ. et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993; 120: 1371-80.
  • 27 Mamdouh Z. et al. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 2003; 421: 748-53.
  • 28 Shaw SK. et al. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol 2001; 167: 2323-30.
  • 29 Feng D. et al. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 1998; 187: 903-15.
  • 30 Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002; 82: 521-33.
  • 31 Cinamon G. et al. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2001; 2: 515-22.
  • 32 Kitayama J. et al. Shear stress affects migration behavior of polymorphonuclear cells arrested on endothelium. Cell Immunol 2000; 203: 39-46.
  • 33 Okada S. et al. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17: 519-28.
  • 34 Delclaux C. et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-95.
  • 35 Huber AR. et al. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 1989; 83: 1122-36.
  • 36 Liao F. et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 1995; 182: 1337-43.
  • 37 Thompson RD. et al. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 2001; 97: 1854-60.
  • 38 Muller WA. et al. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449-60.
  • 39 Duncan GS. et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999; 162: 3022-30.
  • 40 Wakelin MW. et al. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 1996; 184: 229-39.
  • 41 Tanaka Y. et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 1992; 176: 245-53.
  • 42 Berman ME. et al. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 1995; 154: 299-307.
  • 43 Varon D. et al. Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory ago-nist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 1998; 91: 500-7.
  • 44 Pellegatta F. et al. Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils. J Biol Chem 1998; 273: 27768-71.
  • 45 Bohnsack JF. CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6. Blood 1992; 79: 1545-52.
  • 46 Rieu P, Lesavre P, Halbwachs-Mecarelli L. Evidence for integrins other than β2 on polymorphonuclear neutrophils: Expression of α6β1 heterodimer. J Leukoc Biol 1993; 53: 576-82.
  • 47 Sixt M. et al. Cell adhesion and migration properties of β2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules. Relevance for leukocyte extravasation. J Biol Chem 2001; 276: 18878-87.
  • 48 Larbi KY. et al. MMP-9 regulates eosinophil transmigration and expression of CCR3 on transmigrated eosinophils in vivo [abstract]. FASEB J 2003; 667 (04) A1071
  • 49 Kubes P. et al. A novel β1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 1995; 9: 1103-11.
  • 50 Reinhardt PH. et al. Emigrated rat neutrophils adhere to cardiac myocytes via α4 integrin. Circ Res 1997; 81: 196-201.
  • 51 Werr J. et al. β1 integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo . J Exp Med 1998; 187: 2091-6.
  • 52 Cepinskas G. et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. J Cell Sci 1999; 112: 1937-45.
  • 53 Young RE. et al. Neutrophil elastase (NE) plays a non-redundant role in zymosan-induced leukocyte migration [abstract]. FASEB J 2003; 758 (04) A1188
  • 54 Shappell SB. et al. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 1990; 144: 2702-11.
  • 55 Hickey MJ. et al. Varying roles of E-selectin and P-selectin in different microvascular beds in response to antigen. J Immunol 1999; 162: 1137-43.